Crossmark

Molecular detection of Mycobacterium tuberculosis sensitivity to rifampicin and isoniazid in South Gondar Zone, northwest Ethiopia

Crossref DOI link: https://doi.org/10.1186/s12879-019-3978-3

Published Online: 2019-04-25

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alelign, Amir https://orcid.org/0000-0003-2750-7904
Zewude, Aboma

Mohammed, Temesgen

Tolosa, Samuel

Ameni, Gobena

Petros, Beyene
Funding

Funding for this research was provided by:

Addis Ababa University (Grant Ref. No. 0162230106072100101)

National Institutes of Health (US), H3Africa Consortium Program (Grant Ref. No. U01HG007472-01)
License Information

Text and Data Mining valid from 2019-04-25
More Information

Article History

Received: 17 October 2018

Accepted: 11 April 2019

First Online: 25 April 2019

Ethics approval and consent to participate

: Ethical clearance for the study was obtained from the Ethical Committee of Addis Ababa University, Department of Microbial, Cellular and Molecular Biology (Ref. CNSDO/491/07/15). In addition, written permission was sought from the Amhara Regional Health Bureau Research Ethical Committee (Ref. HRTT/1/271/07). Each study participant was consented with a written form and agreed to participate in the study after a clear explanation of the study objectives and patient data confidentiality. In case of study participants less than 18 years old, their parents or guardians were consented.

: Not applicable.

: The authors declare that they have no any competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.